Weekly Administration: Implications for Compliance Daily pills appeal to patients seeking routine and continuity, while weekly injections suit those preferring less frequent dosing
Phase 3 Update: TRIUMPH-4 Results Preliminary data from the ongoing Phase 3 TRIUMPH-4 trial (68 weeks) shows higher numbers than Phase 2: 12mg dose: 28.7% average weight loss (~71 lbs / 32 kg) 9mg dose: 26.4% average weight loss (~64 lbs / 29 kg) Knee osteoarthritis pain: 76% reduction (significant quality-of-life improvement) Blood pressure: Average reduction of 14 mmHg Full Phase 3 results across the TRIUMPH program (obesity, diabetes, cardiovascular outcomes, kidney outcomes) are expected throughout 2026
A Biotin IV treatment for skin can support hydration, reduce dryness, and improve the skin barrier
Apart from the mental trauma that this may cause to any man, it also affects the sexual life of his partner, if she is still sexually active
113 It is mainly used in combination with topical therapies to manage severe papulopustular rosacea
Dr Gordon, Thank you for this excellent article
